Senti Biosciences, Inc.

NasdaqGM:SNTI Stock Report

Mkt Cap: US$80.3m

Senti Biosciences Future Growth

How is Senti Biosciences forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-26.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:SNTI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20255N/A-120N/A1
12/31/20247-94-101-922
12/31/20236-86-89-813
9/30/20225-51-75-38N/A
6/30/20224-46-60-37N/A
3/31/20224-46-49-36N/A
12/31/20213-55-40-35N/A
9/30/20212-45-32-30N/A
12/31/20201-20-25-24N/A
12/31/20190-21-20-18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SNTI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SNTI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SNTI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SNTI's revenue is expected to decline over the next 3 years (-10% per year).

High Growth Revenue: SNTI's revenue is forecast to decline over the next 3 years (-10% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SNTI is forecast to be unprofitable in 3 years.


Discover growth companies